Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study-Reference-Cited by-同舟云学术

Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study

Published:2018-08 Issue:8 Volume:33 Page:1272-1280
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Gilbert Donald L.¹^ORCID,Murphy Tanya K.²,Jankovic Joseph³,Budman Cathy L.⁴,Black Kevin J.⁵^ORCID,Kurlan Roger M.⁶,Coffman Keith A.⁷,McCracken James T.⁸,Juncos Jorge⁹,Grant Jon E.¹⁰,Chipkin Richard E.¹¹

Affiliation:

1. Cincinnati Children's Hospital Medical Center; Department of Pediatrics; Cincinnati Ohio USA

2. University of South Florida; Departments of Pediatrics and Psychiatry; Tampa Florida USA

3. Baylor College of Medicine; Department of Neurology; Houston Texas USA

4. Zucker School of Medicine, Hofstra/Northwell Department of Psychiatry, Northwell Health; Hempstead New York USA

5. Washington University School of Medicine; Departments of Psychiatry, Neurology, Radiology, and Neuroscience; St. Louis Missouri USA

6. Center for Neurological and Neurodevelopmental Health; Voorhees New Jersey USA

7. Children's Mercy Hospital; Kansas City Missouri USA

8. UCLA Semel Institute for Neuroscience; Los Angeles California USA

9. Emory University School of Medicine; Department of Neurology & Brain Health Center; Atlanta Georgia USA

10. University of Chicago; Department of Psychiatry & Behavioral Neuroscience; Chicago Illinois USA

11. Psyadon Pharmaceuticals, Inc.; Germantown Maryland USA

Funder

Psyadon Pharmaceuticals, Inc.

American Academy of Child and Adolescent Psychiatry

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.27457/fullpdf

Reference42 articles.

1. Definition and classification of hyperkinetic movements in childhood;Sanger;Mov Disord.,2010

2. Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs;Mink;Adv Neurol,2006

3. Parallel organization of functionally segregated circuits linking basal ganglia and cortex;Alexander;Annu Rev Neurosci,1986

4. A computational model of action selection in the basal ganglia. I. A new functional anatomy;Gurney;Biol Cybern,2001

5. Pharmacological treatment of Tourette syndrome;Gilbert;Journal of Obsessive Compuls Relat Disord,2014

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Treatment of Tourette Disorder in Children;Journal of Child and Adolescent Psychopharmacology;2024-08-30

2. Tourette syndrome research highlights from 2023;F1000Research;2024-08-09

3. An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms;Expert Review of Neurotherapeutics;2024-07-21

4. Tourette syndrome research highlights from 2023;F1000Research;2024-06-24

5. Fluoroalkoxylated C-3 and C-9 (S)-12-bromostepholidine analogues with D1R antagonist activity;Bioorganic Chemistry;2023-12